Indications
For temporary relief of external itching and soreness in the urogenital region.
Pleo Nig
FDA Label NDC 60681-2102
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Sanum Kehlbeck Gmbh & Co. Kg for the product Pleo Nig (NDC 60681-2102). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications, ingredients, dosage, warning, tamper evident, principal display panel - 20 tablets carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Ingredients
1 tablet contains 250 mg Aspergillus niger 5X in a base of lactose, potato starch, magnesium stearate.
Dosage
1–3 tablets daily, either two hours before breakfast or at bedtime.
Warning
If symptoms persist more than a few days, contact your licensed practitioner. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before taking this product.
Tamper Evident
Do not use this product if imprinted inner blister pack is broken or if imprinted security strip on carton is torn.
Lot #:
Principal Display Panel - 20 Tablets Carton
Pleo™ Nig
TABLETS 5X
Homeopathic
Antipruritic Medicine
lndications: For temporary relief of
external itching and soreness in the
urogenital region.
ORIGINAL ENDERLEIN
20 TABLETS
Principal Display Panel (20 Tablets Carton)
* Please review the disclaimer below.
